• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR RX HERCULINK ELITE STENT SYSTEM; STENT, RENAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR RX HERCULINK ELITE STENT SYSTEM; STENT, RENAL Back to Search Results
Catalog Number 1011540-18
Device Problems Leak/Splash (1354); Improper or Incorrect Procedure or Method (2017); Difficult to Advance (2920); Device Dislodged or Dislocated (2923)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 11/09/2022
Event Type  malfunction  
Manufacturer Narrative
Date of event ¿ estimated.The device location was not provided, and it is unknown if the device is returning for analysis.A follow-up report will be submitted with all additional relevant information.
 
Event Description
It was reported that the procedure was to treat an unknown lesion, in an unknown artery.A 7.0x18mm herculink elite balloon-expandable stent (bes) was advanced to the lesion and at the moment of deploying the stent, contrast was noted in the vessel instead of inflating the balloon.No additional information was provided.
 
Event Description
Subsequent to the initial filed report, the following information was received: it was reported that there was no contrast liquid that flowed out in the patient vessel at the moment of releasing the stent.The stent was noted to be crimped improperly on the balloon; however, an attempt was made to advance the stent delivery system (sds) on the balloon to the lesion in the renal artery.The sds would not advance over the wire.The device was removed and the procedure was successfully completed using two new herculink elite stent systems (6x18mm, 7x18mm) with no reported patient effect or procedural delay.The was no additional information provided.
 
Manufacturer Narrative
H6: medical device problem code 2017 use after damage the device was not returned for analysis.A review of the lot history record revealed no manufacturing nonconformities that would have contributed to this complaint.Additionally, a review of the complaint history identified no other incidents.It was reported that the physician noted from the beginning that the stent was not correctly crimped on the balloon, but he tried to advance it nonetheless, without success.It should be noted that the rx herculink elite peripheral stent system instructions for use specifies: prior to using the rx herculink elite¿ peripheral stent system, carefully remove the system from the package and inspect for bends, kinks, and other damage.Verify that the stent is located between the radiopaque balloon markers.Do not use if any defects are noted.It is unknown if the ifu deviation directly caused or contributed to the reported event.The investigation was unable to determine a conclusive cause for the reported difficulties.Difficult to advance/position (guide wire resistance) may be attributed to several factors including, but are not limited to, product placement technique, guiding catheter support, inner diameter of guide wire lumen, outer diameter of the guide wire, condition of the guide wire, damage to the catheter or accumulation of blood or contrast.Stent dislodgement may be attributed to several factors including, but not limited to, improper or inadequate crimping at the time of manufacture, handling of the stent during preparation, and interaction with the anatomy, accessory devices and/or previously implanted stents.In this case, it is possible the reported stent dislodgement was due to inadvertent mishandling during sheath/stylet removal or unpackaging of the device, causing the reported stent dislodgement.It is also possible that a buildup of procedural contaminants may have contributed to the reported difficult to advance (guide wire resistance); however, without the device to examine, this cannot be confirmed.There is no indication of a product quality issue with respect to manufacture, design, or labeling.H6: medical device problem code 1354 - removed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
RX HERCULINK ELITE STENT SYSTEM
Type of Device
STENT, RENAL
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
Manufacturer (Section G)
ABBOTT VASCULAR, REG # 2024168
26531 ynez road
temecula CA 92591 4628
Manufacturer Contact
lindsey bell
26531 ynez rd.
temecula, CA 92591-4628
9519143996
MDR Report Key16473593
MDR Text Key310618791
Report Number2024168-2023-02139
Device Sequence Number1
Product Code NIN
Combination Product (y/n)N
Reporter Country CodeIT
PMA/PMN Number
P110001
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Pharmacist
Type of Report Initial,Followup
Report Date 04/14/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/02/2023
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number1011540-18
Device Lot Number1100561
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received03/24/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured10/05/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Age68 YR
Patient SexFemale
-
-